Gastroenteritis (S. typhi)

Overview


Plain-Language Overview

Gastroenteritis caused by Salmonella typhi is an infection that affects the digestive system, particularly the intestines. It is caused by swallowing contaminated food or water containing the bacteria Salmonella typhi. This infection leads to symptoms like high fever, abdominal pain, and diarrhea. The bacteria invade the intestinal lining and can spread to the bloodstream, causing a more serious illness called typhoid fever. This condition can significantly impact health by causing dehydration and systemic illness if not treated properly. It mainly affects the gastrointestinal tract but can also involve other organs through bloodstream spread.

Clinical Definition

Gastroenteritis (S. typhi) is a systemic infection caused by the gram-negative bacterium Salmonella enterica serotype typhi. The core pathology involves bacterial invasion of the intestinal mucosa, particularly the Peyer patches in the ileum, leading to inflammation and ulceration. The bacteria can translocate into the bloodstream, causing bacteremia and disseminated infection known as typhoid fever. Clinically, it presents with prolonged high fever, abdominal pain, diarrhea or constipation, and sometimes a characteristic rose spot rash. The infection is transmitted via the fecal-oral route, often through contaminated food or water. It is a major cause of morbidity in endemic areas and requires prompt diagnosis due to potential complications like intestinal perforation and septicemia.

Inciting Event

  • Ingestion of food or water contaminated with Salmonella typhi

  • Exposure to fecal matter from infected individuals or chronic carriers

  • Consumption of raw or undercooked foods in endemic settings

  • Contact with contaminated surfaces in areas with poor sanitation

Latency Period

  • Incubation period typically ranges from 6 to 30 days after exposure

  • Symptoms usually develop within 1 to 3 weeks post ingestion of the bacteria

  • Asymptomatic carriage can persist for months to years in some individuals

Diagnostic Delay

  • Nonspecific early symptoms such as fever and malaise mimic other febrile illnesses

  • Low sensitivity of blood cultures if obtained late or after antibiotic use

  • Limited access to specific diagnostic tests like bone marrow culture in resource-poor settings

  • Misattribution to common viral gastroenteritis or malaria in endemic areas

  • Delayed presentation due to gradual symptom onset

Clinical Presentation


Signs & Symptoms

  • Prolonged high fever with stepwise increase over days

  • Constipation early in illness followed by diarrhea in later stages

  • Headache and malaise are common systemic symptoms

  • Abdominal pain and distension

  • Relative bradycardia despite high fever

  • Rose spots on the trunk appear in about 30% of patients

History of Present Illness

  • Gradual onset of sustained high fever often accompanied by chills and headache

  • Abdominal pain and constipation or diarrhea developing after initial systemic symptoms

  • Relative bradycardia (Faget sign) despite high fever

  • Rose spots on the trunk appearing in some patients during the second week

  • Progressive malaise, anorexia, and hepatosplenomegaly as systemic infection advances

Past Medical History

  • Previous typhoid vaccination status influences susceptibility and severity

  • History of recent travel to endemic regions increases pretest probability

  • Prior episodes of typhoid fever or chronic carrier state may alter clinical course

  • Underlying immunosuppressive conditions such as HIV or malignancy

  • Use of antibiotics prior to presentation can modify symptomatology and culture results

Family History

  • Family members or close contacts with recent typhoid fever increase exposure risk

  • Household members who are chronic carriers may serve as reservoirs for infection

  • No known genetic predisposition or hereditary syndromes associated with typhoid fever

  • Clusters of cases in families often reflect shared environmental exposure

  • No familial pattern of immune deficiency specifically linked to typhoid susceptibility

Physical Exam Findings

  • Fever often high and sustained during the first week of illness

  • Abdominal tenderness, especially in the right lower quadrant

  • Bradycardia relative to fever (Faget sign)

  • Rose spots: faint, salmon-colored maculopapular rash on the trunk

  • Hepatosplenomegaly may be present in some cases

Diagnostic Workup


Diagnostic Criteria

Diagnosis is established by isolating Salmonella typhi from blood cultures, which is the gold standard, especially during the first week of illness. Stool and urine cultures may also be positive but are less sensitive early on. Serologic tests such as the Widal test detect antibodies against S. typhi antigens but have limited specificity and sensitivity. Clinical suspicion is supported by the presence of prolonged fever, abdominal symptoms, and epidemiologic risk factors. Imaging or endoscopy may be used to assess complications but are not diagnostic.

Pathophysiology


Key Mechanisms

  • Invasion of intestinal mucosa by Salmonella typhi leading to mucosal ulceration and inflammation

  • Survival and replication within macrophages allowing systemic dissemination via the reticuloendothelial system

  • Endotoxin release causing systemic inflammatory response and fever

  • Formation of Peyer's patch necrosis resulting in intestinal bleeding or perforation in severe cases

  • Bacteremia leading to seeding of multiple organs and sustained fever

InvolvementDetails
Organs

Small intestine is the initial site of bacterial invasion and ulceration causing abdominal pain and diarrhea.

Liver acts as a site of bacterial replication and immune response during systemic typhoid fever.

Spleen enlarges due to immune activation and serves as a reservoir for infected macrophages.

Tissues

Peyer's patches in the ileum are primary sites of S. typhi invasion and granulomatous inflammation.

Intestinal mucosa undergoes ulceration and necrosis during severe infection leading to clinical symptoms.

Liver tissue may show Kupffer cell hyperplasia and granulomas as part of systemic dissemination.

Cells

Macrophages phagocytose Salmonella typhi and serve as a reservoir for bacterial replication.

Neutrophils are recruited to the intestinal mucosa to contain infection and mediate inflammation.

T lymphocytes mediate adaptive immune responses critical for clearance of intracellular S. typhi.

Chemical Mediators

Tumor necrosis factor-alpha (TNF-α) promotes inflammation and granuloma formation in infected tissues.

Interleukin-6 (IL-6) is elevated during systemic infection and contributes to fever and acute phase response.

Interferon-gamma (IFN-γ) activates macrophages to enhance intracellular killing of S. typhi.

Treatments


Pharmacological Treatments

  • Ceftriaxone

    • Mechanism:
      • Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.

    • Side effects:
      • Allergic reactions

      • Diarrhea

      • Biliary sludge

    • Clinical role:
      • First-line

  • Azithromycin

    • Mechanism:
      • Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.

    • Side effects:
      • Gastrointestinal upset

      • QT prolongation

      • Hepatotoxicity

    • Clinical role:
      • Alternative first-line

  • Fluoroquinolones (e.g., Ciprofloxacin)

    • Mechanism:
      • Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication.

    • Side effects:
      • Tendonitis

      • QT prolongation

      • Photosensitivity

    • Clinical role:
      • Second-line or in resistant cases

Non-pharmacological Treatments

  • Maintain adequate hydration with oral rehydration solutions to prevent dehydration from diarrhea.

  • Implement strict hand hygiene and sanitation measures to reduce transmission of Salmonella typhi.

  • Provide nutritional support to maintain electrolyte balance and energy during illness.

Prevention


Pharmacological Prevention

  • Oral live attenuated Ty21a vaccine provides moderate protection

  • Parenteral Vi capsular polysaccharide vaccine is recommended for travelers

  • Antibiotic prophylaxis is not routinely recommended due to resistance concerns

Non-pharmacological Prevention

  • Safe drinking water and proper sanitation to prevent fecal-oral transmission

  • Hand hygiene especially after using the toilet and before eating

  • Avoidance of high-risk foods such as raw vegetables and street food in endemic areas

  • Public health measures including sewage treatment and food safety regulations

  • Screening and treatment of chronic carriers to reduce community spread

Outcome & Complications


Complications

  • Intestinal hemorrhage due to ulceration of Peyer patches

  • Intestinal perforation leading to peritonitis

  • Sepsis and septic shock from bacteremia

  • Neuropsychiatric manifestations including delirium and encephalopathy

  • Chronic carrier state with persistent gallbladder colonization

Short-term Sequelae Long-term Sequelae
  • Severe dehydration from diarrhea and fever

  • Electrolyte imbalances such as hyponatremia

  • Secondary bacterial infections due to immune suppression

  • Transient hepatitis with elevated transaminases

  • Anemia from gastrointestinal bleeding

  • Chronic carrier state with asymptomatic shedding of S. typhi

  • Gallbladder colonization increasing risk of gallstones and carcinoma

  • Post-infectious reactive arthritis

  • Intestinal strictures from healing ulcers

  • Rarely, neuropsychiatric sequelae persist

Differential Diagnoses


Gastroenteritis (S. typhi) versus Shigellosis

Gastroenteritis (S. typhi)

Shigellosis

Infection with Salmonella typhi

Infection with Shigella species

Gradual onset with stepwise fever progression and relative bradycardia

Acute onset with bloody diarrhea and high fever

Blood culture positive for Salmonella typhi and rose spots on skin

Fecal leukocytes and positive stool culture for Shigella

Gastroenteritis (S. typhi) versus Non-typhoidal Salmonella gastroenteritis

Gastroenteritis (S. typhi)

Non-typhoidal Salmonella gastroenteritis

Infection with Salmonella typhi

Infection with non-typhoidal Salmonella serotypes

Prolonged fever with systemic symptoms and possible typhoid complications

Self-limited diarrhea without systemic symptoms

Requires prompt antibiotic therapy to prevent complications

Usually no antibiotics needed except in high-risk patients

Gastroenteritis (S. typhi) versus Campylobacter jejuni infection

Gastroenteritis (S. typhi)

Campylobacter jejuni infection

Infection with Salmonella typhi

Infection with Campylobacter jejuni

Gradual onset with stepwise fever and constipation or pea soup diarrhea

Acute onset of bloody diarrhea with abdominal cramping

Positive blood culture for Salmonella typhi

Positive stool culture for Campylobacter

Gastroenteritis (S. typhi) versus Enteric fever due to Salmonella paratyphi

Gastroenteritis (S. typhi)

Enteric fever due to Salmonella paratyphi

Infection with Salmonella typhi

Infection with Salmonella paratyphi

Classic typhoid fever with more severe systemic illness

Similar prolonged fever but often milder symptoms

Blood culture positive for S. typhi

Blood culture positive for S. paratyphi

Gastroenteritis (S. typhi) versus Viral gastroenteritis

Gastroenteritis (S. typhi)

Viral gastroenteritis

Prolonged fever with stepwise progression and systemic symptoms

Rapid onset of watery diarrhea and vomiting, usually self-limited

Positive blood culture for Salmonella typhi

No bacteremia; stool viral PCR positive

Requires targeted antibiotic therapy

Supportive care only, no antibiotics

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.